Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96268903 | 9626890 | 3 | F | 20160830 | 20160901 | 20131016 | 20160907 | EXP | CA-GILEAD-2013-0085548 | GILEAD | 80.00 | YR | E | F | Y | 0.00000 | 20160907 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96268903 | 9626890 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10MG PER DAY | MCZF | 22081 | 10 | MG | TABLET | QD | |||||
| 96268903 | 9626890 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | 40 MG, UNK | Y | 0 | 40 | MG | |||||||
| 96268903 | 9626890 | 3 | C | ROCALTROL | CALCITRIOL | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 4 | C | ELTROXIN | LEVOTHYROXINE | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 5 | C | SOFLAX /00061602/ | 2 | U | 0 | ||||||||||||
| 96268903 | 9626890 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 96268903 | 9626890 | 7 | C | DIGOXIN. | DIGOXIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 8 | C | DIGOXIN. | DIGOXIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 9 | C | DIGOXIN. | DIGOXIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 10 | C | WARFARIN | WARFARIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 11 | C | WARFARIN | WARFARIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 12 | C | WARFARIN | WARFARIN | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 13 | C | MULTIVITAMINS | VITAMINS | 1 | U | 0 | |||||||||||
| 96268903 | 9626890 | 14 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | UNK | U | 0 | ||||||||||
| 96268903 | 9626890 | 15 | C | EYE DROPS /00256502/ | OXYMETAZOLINE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96268903 | 9626890 | 1 | Pulmonary hypertension |
| 96268903 | 9626890 | 2 | Pulmonary arterial hypertension |
| 96268903 | 9626890 | 3 | Product used for unknown indication |
| 96268903 | 9626890 | 4 | Product used for unknown indication |
| 96268903 | 9626890 | 6 | Product used for unknown indication |
| 96268903 | 9626890 | 7 | Product used for unknown indication |
| 96268903 | 9626890 | 10 | Product used for unknown indication |
| 96268903 | 9626890 | 14 | Product used for unknown indication |
| 96268903 | 9626890 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96268903 | 9626890 | HO |
| 96268903 | 9626890 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96268903 | 9626890 | Dialysis | |
| 96268903 | 9626890 | Hypotension | |
| 96268903 | 9626890 | Ill-defined disorder | |
| 96268903 | 9626890 | Pneumonia | |
| 96268903 | 9626890 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96268903 | 9626890 | 1 | 20111208 | 0 | ||
| 96268903 | 9626890 | 2 | 20140411 | 0 |